These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29619757)

  • 1. Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy.
    Zhang Y; Liu G; Wei J; Nie G
    Front Med; 2018 Dec; 12(6):667-677. PubMed ID: 29619757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Platelet-Mimicking Nanovehicles.
    Hu Q; Sun W; Qian C; Wang C; Bomba HN; Gu Z
    Adv Mater; 2015 Nov; 27(44):7043-50. PubMed ID: 26416431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and their biomimetics for regenerative medicine and cancer therapies.
    Li Z; Hu S; Cheng K
    J Mater Chem B; 2018 Dec; 6(45):7354-7365. PubMed ID: 31372220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
    Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms.
    Modery-Pawlowski CL; Master AM; Pan V; Howard GP; Sen Gupta A
    Biomacromolecules; 2013 Mar; 14(3):910-9. PubMed ID: 23360320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Therapy of a Naturally Inspired Glycopolymer-Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability.
    Duan Z; Luo Q; Dai X; Li X; Gu L; Zhu H; Tian X; Zhang H; Gong Q; Gu Z; Luo K
    Adv Mater; 2021 Nov; 33(45):e2104594. PubMed ID: 34554623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
    Taurin S; Nehoff H; Greish K
    J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery.
    Safdar A; Wang P; Muhaymin A; Nie G; Li S
    J Control Release; 2024 Sep; 373():128-144. PubMed ID: 38977134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy.
    Mei Y; Wang R; Jiang W; Bo Y; Zhang T; Yu J; Cheng M; Wu Y; Cheng J; Ma W
    Biomater Sci; 2019 Jun; 7(7):2640-2651. PubMed ID: 31090764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Composite Biofilm Biomimetic Nanodrug Delivery Systems for Cancer Treatment.
    Meng Y; Chen S; Wang C; Ni X
    Technol Cancer Res Treat; 2024; 23():15330338241250244. PubMed ID: 38693842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.